HIFU procedures at moderate intensities--effect of large blood vessels.
A three-dimensional computational model is presented for studying the efficacy of high-intensity focused ultrasound (HIFU) procedures targeted near large blood vessels. The analysis applies to procedures performed at intensities below the threshold for cavitation, boiling and highly nonlinear propagation, but high enough to increase tissue temperature a few degrees per second. The model is based upon the linearized KZK equation and the bioheat equation in tissue. In the blood vessel the momentum and energy equations are satisfied. The model is first validated in a tissue phantom, to verify the absence of bubble formation and nonlinear effects. Temperature rise and lesion-volume calculations are then shown for different beam locations and orientations relative to a large vessel. Both single and multiple ablations are considered. Results show that when the vessel is located within about a beam width (few mm) of the ultrasound beam, significant reduction in lesion volume is observed due to blood flow. However, for gaps larger than a beam width, blood flow has no major effect on the lesion formation. Under the clinically representative conditions considered, the lesion volume is reduced about 40% (relative to the no-flow case) when the beam is parallel to the blood vessel, compared to about 20% for a perpendicular orientation. Procedures involving multiple ablation sites are affected less by blood flow than single ablations. The model also suggests that optimally focused transducers can generate lesions that are significantly larger (>2 times) than the ones produced by highly focused beams.
Mechanical, Industrial, and Nuclear Engineering Department, University of Cincinnati, Cincinnati, OH, USA.
P
P
Hariharan
M R
MR
Myers
R K
RK
Banerjee
D003198:Computer Simulation; D006801:Humans; D008962:Models, Theoretical; D009369:Neoplasms / Q000098:blood supply / Q000628:therapy*; D012039:Regional Blood Flow; D013696:Temperature; D014464:Ultrasonic Therapy / Q000379:methods*; D014465:Ultrasonics / Q000009:adverse effects*